Gingko Biloba 60mg packaged in a white and orange bottle containing 120 capsules. The bottle has a blue cap and white lettering.

Now Foods recalled Gingko Biloba 60mg in a Class II action, the FDA tier for products that may cause temporary or medically reversible health effects on Mar 18, 2016.

The FDA listed the reason as an undeclared allergen: "Undeclared soy lecithin in 5 dietary supplements." Allergen mislabeling is the leading cause of U.S. food recalls, because a missing declaration can trigger a reaction in someone who reads the label and believes the product is safe.

Distribution was broad: the FDA record describes it as "Distributed to 499 consignees in AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, VA, VT, WA, WI, WV, WY and PR. The one foreign consignee is Natulab in Japan," which places this among the wider-reach recalls on the site. Consumers across the affected area should check product on hand. The recalling firm is based in Bloomingdale, IL. The recall covers 2 bottles of product. The FDA has Terminated this recall (first reported May 4, 2016), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.